Cellectar Biosciences, Inc.
CLRB
$4.76
$0.061.28%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.04M | 13.91M | 23.29M | 34.26M | 25.87M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.58M | 987.50K | 961.70K | 1.64M | 2.04M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 12.62M | 14.89M | 24.25M | 35.90M | 27.91M |
|
|
|||||
| Total Current Assets | 12.62M | 14.89M | 24.25M | 35.90M | 27.91M |
| Net Property, Plant & Equipment | 1.05M | 1.12M | 1.19M | 1.36M | 1.45M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 29.80K | 29.80K | 29.80K | 29.80K | 29.80K |
| Total Assets | 13.70M | 16.04M | 25.47M | 37.29M | 29.38M |
|
|
|||||
| Total Accounts Payable | 4.68M | 3.87M | 4.11M | 8.30M | 6.46M |
| Total Accrued Expenses | -- | -- | 3.48M | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 92.00K | 88.10K | 84.40K | 80.80K | 77.30K |
| Total Finance Division Other Current Liabilities | 1.10M | 2.06M | 1.72M | 11.93M | 8.63M |
| Total Other Current Liabilities | 1.10M | 2.06M | 1.72M | 11.93M | 8.63M |
| Total Current Liabilities | 5.87M | 6.02M | 9.39M | 20.31M | 15.17M |
|
|
|||||
| Total Current Liabilities | 5.87M | 6.02M | 9.39M | 20.31M | 15.17M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 361.50K | 386.20K | 409.60K | 431.90K | 453.50K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.23M | 6.41M | 9.80M | 20.75M | 15.62M |
|
|
|||||
| Common Stock & APIC | 264.96M | 261.68M | 261.12M | 246.54M | 234.86M |
| Retained Earnings | -259.39M | -253.95M | -247.34M | -244.99M | -230.32M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 5.56M | 7.73M | 13.77M | 1.55M | 4.54M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.90M | 1.90M | 1.90M | 15.00M | 9.23M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.90M | 1.90M | 1.90M | 15.00M | 9.23M |
|
|
|||||
| Total Common Equity | 5.56M | 7.73M | 13.77M | 1.55M | 4.54M |
| Total Preferred Equity | 1.90M | 1.90M | 1.90M | 15.00M | 9.23M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.47M | 9.64M | 15.68M | 16.55M | 13.76M |
|
|
|||||